The Olfactory Bulb Provides a Radioresistant Niche for Glioblastoma Cells.


Journal

International journal of radiation oncology, biology, physics
ISSN: 1879-355X
Titre abrégé: Int J Radiat Oncol Biol Phys
Pays: United States
ID NLM: 7603616

Informations de publication

Date de publication:
01 05 2020
Historique:
received: 24 10 2019
revised: 10 01 2020
accepted: 13 01 2020
pubmed: 29 1 2020
medline: 6 10 2020
entrez: 29 1 2020
Statut: ppublish

Résumé

The various microenvironments that exist within the brain combined with the invasive nature of glioblastoma (GBM) creates the potential for a topographic influence on tumor cell radiosensitivity. The aim of this study was to determine whether specific brain microenvironments differentially influence tumor cell radioresponse. GBM stem-like cells were implanted into the right striatum of nude mice. To measure radiosensitivity, proliferation status of individual tumor cells was determined according to the incorporation of 5-chloro-2'-deoxyuridine delivered at 4, 12, and 20 days after brain irradiation. As an additional measure of radiosensitivity, the percentage of human cells in the right hemisphere and the olfactory bulb were defined using digital droplet polymerase chain reaction. Targeted gene expression profiling was accomplished using NanoString analysis. Tumor cells were detected throughout the striatum, corpus callosum, and olfactory bulb. After an initial loss of proliferating tumor cells in the corpus callosum and striatum after irradiation, there was only a minor recovery by 20 days. In contrast, the proliferation of tumor cells located in the olfactory bulb began to recover at 4 days and returned to unirradiated levels by day 12 postirradiation. The percentage of human cells in the right hemisphere and the olfactory bulb after irradiation also suggested that the tumor cells in the olfactory bulb were relatively radioresistant. Gene expression profiling identified consistent differences between tumor cells residing in the olfactory bulb and those in the right hemisphere. These results suggest that the olfactory bulb provides a radioresistant niche for GBM cells.

Identifiants

pubmed: 31987963
pii: S0360-3016(20)30066-3
doi: 10.1016/j.ijrobp.2020.01.007
pmc: PMC7152565
mid: NIHMS1552019
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

194-201

Subventions

Organisme : CCR NIH HHS
ID : HHSN261200800001C
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA BC011372
Pays : United States

Informations de copyright

Published by Elsevier Inc.

Références

Glia. 2011 Aug;59(8):1148-54
pubmed: 21547954
Mol Cancer Ther. 2018 Jun;17(6):1207-1216
pubmed: 29549168
J Clin Oncol. 2002 Mar 15;20(6):1635-42
pubmed: 11896114
Nat Rev Cancer. 2006 Jun;6(6):425-36
pubmed: 16723989
Nature. 2019 Sep;573(7775):539-545
pubmed: 31534222
J Clin Oncol. 2003 Apr 15;21(8):1624-36
pubmed: 12697889
Curr Protoc Mol Biol. 2011 Apr;Chapter 25:Unit25B.10
pubmed: 21472696
Clin Cancer Res. 2010 Dec 15;16(24):6049-59
pubmed: 21037023
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
J Pathol. 2018 Mar;244(3):260-264
pubmed: 29282720
Nat Rev Cancer. 2008 Dec;8(12):957-67
pubmed: 19005492
Mol Cancer Res. 2009 Apr;7(4):489-97
pubmed: 19372578
Cancer Cell. 2006 May;9(5):391-403
pubmed: 16697959
Neoplasia. 2012 Feb;14(2):150-8
pubmed: 22431923
Nature. 2019 Sep;573(7775):532-538
pubmed: 31534219
Radiother Oncol. 2002 Sep;64(3):259-73
pubmed: 12242114
Nat Methods. 2005 Mar;2(3):167-9
pubmed: 15782184

Auteurs

Cindy R Timme (CR)

Radiation Oncology Branch, National Cancer Institute, Bethesda, Maryland.

Charlotte Degorre-Kerbaul (C)

Radiation Oncology Branch, National Cancer Institute, Bethesda, Maryland.

Joseph H McAbee (JH)

Radiation Oncology Branch, National Cancer Institute, Bethesda, Maryland; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom; Wake Forest University School of Medicine, Winston-Salem, North Carolina.

Barbara H Rath (BH)

Radiation Oncology Branch, National Cancer Institute, Bethesda, Maryland.

Xiaolin Wu (X)

Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland.

Kevin Camphausen (K)

Radiation Oncology Branch, National Cancer Institute, Bethesda, Maryland.

Philip J Tofilon (PJ)

Radiation Oncology Branch, National Cancer Institute, Bethesda, Maryland. Electronic address: philip.tofilon@nih.gov.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH